Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Brain markers and onset of major depressive disorder in at-risk youth

FY 2021-22

Summary
Major depressive disorder (MDD) affects 11% of Canadians aged 15-24 and the heritability of MDD is estimated to be 40%. Current research aims to identify biological markers of MDD that precede symptom onset in order to predict prognosis. Combined transcranial magnetic stimulation and electroencephalography (TMS-EEG) allows researchers to study brain function by non-invasively stimulating brain regions and then measuring induced activity. Studies have shown that a negative peak in activity forms 100 milliseconds after a TMS pulse (N100) and that youth and adults with MDD have significantly larger N100 peak amplitudes than healthy controls. Despite the high heritability of MDD, the predictive utility of the N100 marker in at-risk youth has not been studied. The proposed research will address this gap by determining the relationship between parental MDD and N100 amplitudes in at-risk youth and the utility of N100 amplitudes to predict MDD onset. It is hypothesized that N100 amplitudes will be associated with parental MDD severity, will serve as a significant predictor of MDD onset, and will be stable in youth who do not develop MDD. A minimum of 80 youth will be recruited from a longitudinal study and will have TMS-EEG data collected at baseline. Parental MDD will be assessed at baseline and youth will complete MDD questionnaires at baseline and 9-month intervals. N100 peak amplitudes will be quantified and correlated with parental MDD scores. The relationship between N100 amplitudes and MDD onset will be investigated using 9- and 18-month follow-up data. Knowledge of family history and presence of brain markers in youth will allow healthcare providers to implement strategies to delay the onset of MDD and reduce the severity of symptoms.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466565
Name
Krile Louisa R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Brain markers and onset of major depressive disorder in at-risk youth
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Electroencephalography; Family History; Genetic Predisposition; Major Depressive Disorder; Mental Health; Neurostimulation; Risk Factors
Abstract
Major depressive disorder (MDD) affects 11% of Canadians aged 15-24 and the heritability of MDD is estimated to be 40%. Current research aims to identify biological markers of MDD that precede symptom onset in order to predict prognosis. Combined transcranial magnetic stimulation and electroencephalography (TMS-EEG) allows researchers to study brain function by non-invasively stimulating brain regions and then measuring induced activity. Studies have shown that a negative peak in activity forms 100 milliseconds after a TMS pulse (N100) and that youth and adults with MDD have significantly larger N100 peak amplitudes than healthy controls. Despite the high heritability of MDD, the predictive utility of the N100 marker in at-risk youth has not been studied. The proposed research will address this gap by determining the relationship between parental MDD and N100 amplitudes in at-risk youth and the utility of N100 amplitudes to predict MDD onset. It is hypothesized that N100 amplitudes will be associated with parental MDD severity, will serve as a significant predictor of MDD onset, and will be stable in youth who do not develop MDD. A minimum of 80 youth will be recruited from a longitudinal study and will have TMS-EEG data collected at baseline. Parental MDD will be assessed at baseline and youth will complete MDD questionnaires at baseline and 9-month intervals. N100 peak amplitudes will be quantified and correlated with parental MDD scores. The relationship between N100 amplitudes and MDD onset will be investigated using 9- and 18-month follow-up data. Knowledge of family history and presence of brain markers in youth will allow healthcare providers to implement strategies to delay the onset of MDD and reduce the severity of symptoms.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Krile, Louisa R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~